SG11202010459XA - Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors - Google Patents
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptorsInfo
- Publication number
- SG11202010459XA SG11202010459XA SG11202010459XA SG11202010459XA SG11202010459XA SG 11202010459X A SG11202010459X A SG 11202010459XA SG 11202010459X A SG11202010459X A SG 11202010459XA SG 11202010459X A SG11202010459X A SG 11202010459XA SG 11202010459X A SG11202010459X A SG 11202010459XA
- Authority
- SG
- Singapore
- Prior art keywords
- spiropiperidine
- nicotinic acetylcholine
- allosteric modulators
- acetylcholine receptors
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862665091P | 2018-05-01 | 2018-05-01 | |
| PCT/US2019/029561 WO2019212927A1 (en) | 2018-05-01 | 2019-04-29 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202010459XA true SG11202010459XA (en) | 2020-11-27 |
Family
ID=66429709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202010459XA SG11202010459XA (en) | 2018-05-01 | 2019-04-29 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US11332463B2 (ko) |
| EP (1) | EP3788043A1 (ko) |
| JP (1) | JP7073533B2 (ko) |
| KR (1) | KR102587811B1 (ko) |
| CN (1) | CN112119076A (ko) |
| AR (1) | AR115065A1 (ko) |
| AU (1) | AU2019262917B2 (ko) |
| BR (1) | BR112020022088A8 (ko) |
| CA (1) | CA3098583C (ko) |
| CL (2) | CL2020002820A1 (ko) |
| CO (1) | CO2020013462A2 (ko) |
| CR (1) | CR20200509A (ko) |
| EA (1) | EA202092608A1 (ko) |
| EC (1) | ECSP20067907A (ko) |
| GE (1) | GEP20227409B (ko) |
| IL (1) | IL278154A (ko) |
| JO (1) | JOP20200272A1 (ko) |
| MA (1) | MA52482A (ko) |
| MX (1) | MX2020011489A (ko) |
| NI (1) | NI202000074A (ko) |
| PE (1) | PE20210052A1 (ko) |
| PH (1) | PH12020551779A1 (ko) |
| SG (1) | SG11202010459XA (ko) |
| UA (1) | UA126834C2 (ko) |
| WO (1) | WO2019212927A1 (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| US20220119351A1 (en) * | 2019-05-02 | 2022-04-21 | Merck Sharp & Dohme Corp. | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
| EP4054569A4 (en) * | 2019-11-05 | 2023-10-25 | Merck Sharp & Dohme LLC | SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS |
| JP2023510111A (ja) * | 2019-12-19 | 2023-03-13 | クリア、スペイン、エセ、ア、ウ | ウパダシチニブの調製のための方法及び中間体 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044010A1 (es) | 2003-04-11 | 2005-08-24 | Janssen Pharmaceutica Nv | Uso de derivados de 4-fenil-4- [1h-imidazol-2-il]- piperidina sustituidos como agonistas delta opioideos no peptidos selectivos, con actividad antidepresiva y ansiolitica |
| JP5362729B2 (ja) | 2007-10-04 | 2013-12-11 | エフ．ホフマン−ラ ロシュ アーゲー | シクロプロピルアリールアミド誘導体及びその使用 |
| KR101925971B1 (ko) | 2011-01-28 | 2018-12-06 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| WO2012103583A1 (en) | 2011-02-02 | 2012-08-09 | Bionomics Limited | Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof. |
| UA111746C2 (uk) | 2011-07-08 | 2016-06-10 | Х. Луннбек А/С | Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну |
| US8598213B2 (en) | 2011-07-08 | 2013-12-03 | H. Lundbeck A/S | Positive allosteric modulators of nicotinic acetylcholine receptor |
| WO2014006117A1 (en) | 2012-07-06 | 2014-01-09 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
| JP2015529651A (ja) | 2012-08-01 | 2015-10-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | α７ニコチン性アセチルコリン受容体モジュレーターおよびそれらの使用−Ｉ |
| EP2905279A4 (en) * | 2012-10-02 | 2016-04-20 | Sumitomo Dainippon Pharma Co Ltd | imidazole |
| JP2016504306A (ja) | 2012-12-10 | 2016-02-12 | ハー・ルンドベック・アクチエゼルスカベット | ニコチン性アセチルコリン受容体の新規な陽性アロステリックモジュレータ |
| US10208081B2 (en) | 2014-11-26 | 2019-02-19 | Enanta Pharmaceuticals, Inc. | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof |
| US10800780B2 (en) | 2015-12-24 | 2020-10-13 | Genentech, Inc. | TDO2 Inhibitors |
| HRP20211960T1 (hr) | 2016-03-22 | 2022-03-18 | Merck Sharp & Dohme Corp. | Alosterični modulatori nikotinskih acetilcolinskih receptora |
-
2019
- 2019-04-29 JP JP2020560807A patent/JP7073533B2/ja active Active
- 2019-04-29 KR KR1020207034124A patent/KR102587811B1/ko active IP Right Grant
- 2019-04-29 CA CA3098583A patent/CA3098583C/en active Active
- 2019-04-29 CR CR20200509A patent/CR20200509A/es unknown
- 2019-04-29 EP EP19722488.4A patent/EP3788043A1/en active Pending
- 2019-04-29 PE PE2020001722A patent/PE20210052A1/es unknown
- 2019-04-29 WO PCT/US2019/029561 patent/WO2019212927A1/en unknown
- 2019-04-29 GE GEAP201915499A patent/GEP20227409B/en unknown
- 2019-04-29 JO JOP/2020/0272A patent/JOP20200272A1/ar unknown
- 2019-04-29 AU AU2019262917A patent/AU2019262917B2/en active Active
- 2019-04-29 SG SG11202010459XA patent/SG11202010459XA/en unknown
- 2019-04-29 CN CN201980029616.2A patent/CN112119076A/zh active Pending
- 2019-04-29 US US17/049,653 patent/US11332463B2/en active Active
- 2019-04-29 BR BR112020022088A patent/BR112020022088A8/pt unknown
- 2019-04-29 MX MX2020011489A patent/MX2020011489A/es unknown
- 2019-04-29 MA MA052482A patent/MA52482A/fr unknown
- 2019-04-29 AR ARP190101126A patent/AR115065A1/es unknown
- 2019-04-29 UA UAA202007589A patent/UA126834C2/uk unknown
- 2019-04-29 EA EA202092608A patent/EA202092608A1/ru unknown
-
2020
- 2020-10-19 IL IL278154A patent/IL278154A/en unknown
- 2020-10-26 EC ECSENADI202067907A patent/ECSP20067907A/es unknown
- 2020-10-26 CO CONC2020/0013462A patent/CO2020013462A2/es unknown
- 2020-10-27 PH PH12020551779A patent/PH12020551779A1/en unknown
- 2020-10-27 NI NI202000074A patent/NI202000074A/es unknown
- 2020-10-29 CL CL2020002820A patent/CL2020002820A1/es unknown
-
2021
- 2021-07-06 CL CL2021001795A patent/CL2021001795A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11332463B2 (en) | 2022-05-17 |
| IL278154A (en) | 2020-11-30 |
| JOP20200272A1 (ar) | 2020-11-01 |
| BR112020022088A2 (pt) | 2021-02-02 |
| CR20200509A (es) | 2020-12-23 |
| JP2021523102A (ja) | 2021-09-02 |
| BR112020022088A8 (pt) | 2023-02-07 |
| MA52482A (fr) | 2021-03-10 |
| CA3098583C (en) | 2023-05-16 |
| PH12020551779A1 (en) | 2021-06-07 |
| GEP20227409B (en) | 2022-09-12 |
| CA3098583A1 (en) | 2019-11-07 |
| AU2019262917A1 (en) | 2020-11-05 |
| US20210070745A1 (en) | 2021-03-11 |
| EA202092608A1 (ru) | 2021-03-02 |
| PE20210052A1 (es) | 2021-01-08 |
| AU2019262917B2 (en) | 2021-12-23 |
| JP7073533B2 (ja) | 2022-05-23 |
| CN112119076A (zh) | 2020-12-22 |
| CL2020002820A1 (es) | 2021-02-19 |
| MX2020011489A (es) | 2020-12-07 |
| KR102587811B1 (ko) | 2023-10-11 |
| KR20210005697A (ko) | 2021-01-14 |
| TW202014419A (zh) | 2020-04-16 |
| CO2020013462A2 (es) | 2020-11-10 |
| CL2021001795A1 (es) | 2021-12-24 |
| ECSP20067907A (es) | 2021-02-26 |
| AR115065A1 (es) | 2020-11-25 |
| WO2019212927A1 (en) | 2019-11-07 |
| UA126834C2 (uk) | 2023-02-08 |
| EP3788043A1 (en) | 2021-03-10 |
| NI202000074A (es) | 2021-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261807A (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| ZA201808219B (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 | |
| IL278154A (en) | Spiropiperidine compounds as allosteric modulators of nicotinic acetylcholine receptors | |
| IL264951B (en) | Positive allosteric modulators of the m1 muscarinic receptor | |
| IL261058A (en) | Positive allosteric modulators of the muscarinic acetylcholine m1 receptor | |
| IL272017A (en) | Positive allosteric modulators of muscarinic m2 receptor | |
| IL281492A (en) | Modulators of PNPLA3 expression | |
| EP3393472A4 (en) | ACETYLCHOLINE M4 MUSCARINIC RECEPTOR TYPE 3- (1H-PYRAZOL-4-YL) PYRIDINE MODULATORS | |
| IL275457A (en) | Spiro exo-aza inhibitors of the MENIN-MLL interaction | |
| IL274322A (en) | Spirocyclic compounds as paranoid X receptor modulators | |
| IL283967A (en) | Modulators of hsd17b13 expression | |
| EP3534901A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP3558309A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE ACETYLCHOLIN M4 MUSCARINIC RECEPTOR | |
| EP3558946A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINE ACETYL CHOLINE RECEPTOR M4 | |
| EP3544961A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINE ACETYLCHOLINE RECEPTOR M4 | |
| EP3684357A4 (en) | HETEROARYLIC ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR | |
| EP3534888A4 (en) | BICYCLIC HETERARYARYL ALLOSTERIC MODULATORS SUBSTITUTED BY NICOTINIC ACETYLCHOLINE RECEPTORS | |
| IL278740B1 (en) | Methods for using splicing modulators | |
| EP3962483A4 (en) | ALLOSTERIC SPIROPIPERIDINE MODULATORS OF NICOTINE ACETYLCHOLINE RECEPTORS | |
| EP3534889A4 (en) | SUBSTITUTED 6-PIECE ARYL OR HETEROARYL ALLOSTERIC MODULATORS OF NICOTINE ACETYL CHOLINE RECEPTORS | |
| EP4054569A4 (en) | SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | |
| EP3830083A4 (en) | ALLOSTERIC MODULATORS OF THE ?U-OPIOID RECEPTOR | |
| EP3463361A4 (en) | DUAL MODULATORS OF BOTH MU- AND KAPPA-OPIOD RECEPTORS |